Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xopenex

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of healthcare services. The company manufactures a pharmaceutical under the Xopenex brand which is used in the treatment and prevention of bronchospasm in adults, adolescents and children.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 84 Waterford Drive
  • Marlborough, MA 01752
  • United States

Xopenex Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Xopenex‘s full profile, request access.

Request full access to PitchBook

Xopenex Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Xopenex‘s full profile, request access.

Request full access to PitchBook